Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
In order to identify the epidemiological features of the incidence of COVID-19 in the Jalal-Abad region of the Kyrgyz Republic, a retrospective epidemiological analysis was carried out, according to the results of which the following was established. Jalal-Abad region was the leader in the number of cases of new coronavirus infection in the Kyrgyz Republic in 2020. The incidence had a pronounced rise with a maximum in October. The most disadvantaged in this period in terms of the incidence of a new coronavirus infection were Mailuu-SUU (1663.2 per 100 thousand), Chatkal (1000.8 per 100 thousand), Jalal-Abad (677.6 per 100 thousand) and Kara-Kol (532.0 per 100 thousand). In all territorial entities of the region, cases of COVID-19 were registered mainly among the adult population. The diseases of the new coronavirus infection in children were isolated. The greatest proportion of cases occurred in people aged 30–64 years, which is due to the larger number of this group, as well as the most severe course of the disease. Most often, the diseases occurred in the form of moderate severity (47.2 %) and mild (22.7 %). At the same time, according to the results of laboratory studies, it was possible to identify 14.9 % of cases of the disease with an asymptomatic course. The condition was regarded as severe in 12.2 % of cases, extremely severe — in 3 %. High focality was revealed. The share of foci with two cases was 63.2 %, with three — 19.3 %, four — 6.2 %, five — 5.5 %, six or more — 5.8 %. Most foci with four or more cases were registered in Ala-Buka, Suzak, Toktogul, Nooken districts and the city of Tash-Komur. The study made it possible to identify the features of the course of the epidemic process of a new coronavirus infection, which made it possible to adjust the implementation of preventive and anti-epidemic measures in the future, to reduce the rate of focality, to minimize mortality. At the same time, the main role in the prevention of COVID-19 from the moment of registration of vaccines against this infection is assigned to specific prevention.
In order to identify the epidemiological features of the incidence of COVID-19 in the Jalal-Abad region of the Kyrgyz Republic, a retrospective epidemiological analysis was carried out, according to the results of which the following was established. Jalal-Abad region was the leader in the number of cases of new coronavirus infection in the Kyrgyz Republic in 2020. The incidence had a pronounced rise with a maximum in October. The most disadvantaged in this period in terms of the incidence of a new coronavirus infection were Mailuu-SUU (1663.2 per 100 thousand), Chatkal (1000.8 per 100 thousand), Jalal-Abad (677.6 per 100 thousand) and Kara-Kol (532.0 per 100 thousand). In all territorial entities of the region, cases of COVID-19 were registered mainly among the adult population. The diseases of the new coronavirus infection in children were isolated. The greatest proportion of cases occurred in people aged 30–64 years, which is due to the larger number of this group, as well as the most severe course of the disease. Most often, the diseases occurred in the form of moderate severity (47.2 %) and mild (22.7 %). At the same time, according to the results of laboratory studies, it was possible to identify 14.9 % of cases of the disease with an asymptomatic course. The condition was regarded as severe in 12.2 % of cases, extremely severe — in 3 %. High focality was revealed. The share of foci with two cases was 63.2 %, with three — 19.3 %, four — 6.2 %, five — 5.5 %, six or more — 5.8 %. Most foci with four or more cases were registered in Ala-Buka, Suzak, Toktogul, Nooken districts and the city of Tash-Komur. The study made it possible to identify the features of the course of the epidemic process of a new coronavirus infection, which made it possible to adjust the implementation of preventive and anti-epidemic measures in the future, to reduce the rate of focality, to minimize mortality. At the same time, the main role in the prevention of COVID-19 from the moment of registration of vaccines against this infection is assigned to specific prevention.
Introduction: Today, we are witnessing the process of forming a fundamentally new epidemiological situation on infectious mononucleosis. Over the past decade, a general increase in the incidence of infectious mononucleosis, its proportion in the structure of respiratory tract infections, and economic importance was noted in Russia. Information about the epidemic process of infectious mononucleosis in different areas is limited. Our objective was to study the features of the epidemic process of infectious mononucleosis in the Nizhny Novgorod Region in 2010–2019. Methods: We conducted a retrospective epidemiological analysis of the incidence of infectious mononucleosis in the Nizhny Novgorod Region for 2010–2019 based on official statistics using standard statistical approaches. Results and discussion: The long-term incidence rate of infectious mononucleosis in the Nizhny Novgorod Region was stable (+0.6 %) with the long-term average rate of 12.6 ± 0.6 ‰оо. An autumn-winter-spring seasonality with two distinct peaks (in November–December and May) was revealed. The majority of cases were children aged 0–14 years (72.8 ± 2.2 %). The highest incidence rates were regis�tered in the age groups of 1–2 and 3-6 years. We established a reverse trend in the disease incidence among children aged 0–6 (decrease) and 7 years and older (increase). Adolescents aged 15–17 demonstrated the most pronounced growth rate (+7.5 %). The typical annual dynamics in adults was distinguished by a clear spring-summer seasonality, the absence of a characteristic growth in the autumn months, and a low rate in December. The identified features of the epidemic process in different age groups require clarification and detailing. Conclusions: We established recent patterns and features of the epidemic process of infectious mononucleosis in the Nizhny Novgorod Region. This work is an important component of epidemiological surveillance of infection and a scientific basis for improving the existing system of preventive and anti-epidemic measures.
Introduction. The Epstein–Barr virus (EBV) is one of the most common pathogens — it infects 90% of the world’s population. However, specific characteristics of the EBV infection epidemic process remain unidentified. The previous studies focusing on assessment of incidence rates for infectious mononucleosis (IM) tend to ignore the serological status of the population.The aim of the study was to identify epidemiological characteristics and assess the prevalence of serological markers for EBV infection for further epidemic control measures development.Materials and methods. In Moscow, the thorough analysis was performed using the data on IM incidence (Form 2 "Data on Infectious and Parasitic Diseases") and test results for 138,232 people checked for presence of VCA IgG, EBNA IgG, VCA IgM, EA IgG, and EBV DNA in their blood and saliva in 2011–2020.Results. The periodic pattern of IM incidence was discovered, demonstrating the repetitive peaks every 9 to 11 years and a strong direct correlative relationship with detection rates for active EBV infection markers. The intra-annual dynamics of IM incidence is characterized by a seasonal upswing during cold seasons of the year, reaching its peaks in October, November, or February and associated with a marked decrease in the VCA IgG and EBNA IgG seroprevalence. Children within the 1 to 17-year age range are groups at risk for acquiring primary infection, demonstrating significantly lower detection rates for chronic EBV infection (VCA IgG and EBNA IgG) markers and higher rates for VCA IgM and EBV DNA markers in blood compared to adults. The contribution of adult population to the epidemic process is formed through reactivation of chronic infection, which is observed primarily among women.Conclusion. The identified characteristics are essential for comprehensive understanding of the EBV infection epidemic process and can be used for developing preventive and anti-epidemic measures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.